SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027742
Filing Date
2023-06-13
Accepted
2023-06-13 16:54:39
Documents
12
Period of Report
2023-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20230613.htm   iXBRL 8-K 82194
  Complete submission text file 0000950170-23-027742.txt   203794

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230613_pre.xml EX-101.PRE 10289
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230613.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230613_lab.xml EX-101.LAB 14018
6 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230613_htm.xml XML 4911
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 231011954
SIC: 2834 Pharmaceutical Preparations